Lipocine News, Lipocine Quote, LPCN Quote

Lipocine (NQ:LPCN) Delayed: 4.84 -0.52 (9.7%)

Prev. Close

$5.36

Open

$5.30

52 Wk High

$14.80

52 Wk Low

$2.51

Day High

$5.30

Day Low

$4.68

P/E

N/A

EPS

$-0.69

Volume

35,031

Apr 11, 2024 07:25 AM Form 8-K Lipocine Inc. For: Apr 11
Apr 11, 2024 07:02 AM Lipocine (LPCN) Reports Positive LPCN 2401 Clinical Results
Apr 11, 2024 07:00 AM Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
Mar 28, 2024 08:01 AM Lipocine (LPCN) Reports Positive Week 52 Results from LPCN 1148 Phase 2 Study
Mar 28, 2024 08:00 AM Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
Mar 28, 2024 06:26 AM Form 8-K Lipocine Inc. For: Mar 28
Mar 25, 2024 08:00 AM Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154
Mar 25, 2024 06:15 AM Form 8-K Lipocine Inc. For: Mar 25
Mar 12, 2024 05:53 PM Form 4 Lipocine Inc. For: Mar 08 Filed by: Patel Mahesh V.
Mar 12, 2024 05:51 PM Form 4 Lipocine Inc. For: Mar 08 Filed by: Fogarty Krista

Entities mentioned with LPCN